Literature DB >> 19692622

Toll-like receptor 3 ligand and retinoic acid enhance germinal center formation and increase the tetanus toxoid vaccine response.

Yifan Ma1, A Catharine Ross.   

Abstract

Immunizations with T-cell-dependent antigens induce the formation of germinal centers (GC), unique lymphoid microenvironments in which antigen-activated B cells undergo class switching, affinity maturation, and differentiation into memory B cells. Poly(I:C) (PIC), a double-stranded RNA, and retinoic acid (RA), a metabolite of vitamin A which induces cell differentiation, have been shown to augment both primary and memory anti-tetanus toxoid (anti-TT) IgG responses. However, their influence on the GC reaction is unknown. In the present study, 6-week-old C57BL/6 mice were immunized with TT and cotreated with PIC, RA, or both. The splenic GC reaction was evaluated using immunofluorescence staining 10 days after TT priming. Each treatment enhanced the TT-induced GC formation (number of GC/follicle and GC area) about two- to threefold, which correlated with the titers of plasma anti-TT immunoglobulin G (IgG). Isotype switching to IgG1 was dramatically stimulated, with the greatest increase in IgG1-positive GC B cells induced by RA-PIC (P < 0.001). Moreover, PIC alone and RA-PIC robustly promoted the formation of the follicular dendritic cell (FDC) network in the GC light zone. PIC and RA-PIC also increased IgG1-positive B cells in the periarterial lymphatic sheath regions, where most IgG1-positive cells were plasma cells (CD138/syndecan-1 positive), suggesting that plasma cell generation was also enhanced in non-GC regions. The stimulation of several processes, including antigen-induced GC formation, isotype switching, FDC network formation within GC, and plasma cell differentiation by RA and/or PIC, suggests that this nutritional-immunological combination could be an effective means of promoting a robust vaccine response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692622      PMCID: PMC2756847          DOI: 10.1128/CVI.00282-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  62 in total

Review 1.  Microanatomy and function of the spleen.

Authors:  B Steiniger; P Barth
Journal:  Adv Anat Embryol Cell Biol       Date:  2000       Impact factor: 1.231

2.  Immunoprophylactic strategies against respiratory influenza virus infection.

Authors:  E G Saravolac; D Sabuda; C Crist; K Blasetti; G Schnell; H Yang; M Kende; H B Levy; J P Wong
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

3.  Identification of murine germinal center B cell subsets defined by the expression of surface isotypes and differentiation antigens.

Authors:  S M Shinall; M Gonzalez-Fernandez; R J Noelle; T J Waldschmidt
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

Review 4.  Vitamin A, infection, and immune function.

Authors:  C B Stephensen
Journal:  Annu Rev Nutr       Date:  2001       Impact factor: 11.848

Review 5.  Follicular stromal cells and lymphocyte homing to follicles.

Authors:  J G Cyster; K M Ansel; K Reif; E H Ekland; P L Hyman; H L Tang; S A Luther; V N Ngo
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

6.  All-trans-retinoic acid and polyriboinosinoic:polyribocytidylic acid cooperate to elevate anti-tetanus immunoglobulin G and immunoglobulin M responses in vitamin A-deficient lewis rats and Balb/c mice.

Authors:  K L DeCicco; A C Ross
Journal:  Proc Nutr Soc       Date:  2000-11       Impact factor: 6.297

7.  Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo.

Authors:  C Angelin-Duclos; G Cattoretti; K I Lin; K Calame
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

8.  Retinoic acid and polyriboinosinic acid act synergistically to enhance the antibody response to tetanus toxoid during vitamin A deficiency: possible involvement of interleukin-2 receptor-beta, signal transducer and activator of transcription-1, and interferon regulatory factor-1.

Authors:  K L DeCicco; R Zolfaghari; N q Li; A C Ross
Journal:  J Infect Dis       Date:  2000-09       Impact factor: 5.226

Review 9.  Augmentation of antibody responses by retinoic acid and costimulatory molecules.

Authors:  A Catharine Ross; Qiuyan Chen; Yifan Ma
Journal:  Semin Immunol       Date:  2008-09-25       Impact factor: 11.130

Review 10.  TLR3: interferon induction by double-stranded RNA including poly(I:C).

Authors:  Misako Matsumoto; Tsukasa Seya
Journal:  Adv Drug Deliv Rev       Date:  2008-01-02       Impact factor: 15.470

View more
  11 in total

1.  Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice.

Authors:  Swantje I Hammerschmidt; Michaela Friedrichsen; Jasmin Boelter; Marcin Lyszkiewicz; Elisabeth Kremmer; Oliver Pabst; Reinhold Förster
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

2.  Oral vitamin A and retinoic acid supplementation stimulates antibody production and splenic Stra6 expression in tetanus toxoid-immunized mice.

Authors:  Libo Tan; Amanda E Wray; A Catharine Ross
Journal:  J Nutr       Date:  2012-06-27       Impact factor: 4.798

Review 3.  Vitamin A and retinoic acid in T cell-related immunity.

Authors:  A Catharine Ross
Journal:  Am J Clin Nutr       Date:  2012-10-10       Impact factor: 7.045

4.  Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mice.

Authors:  Kathrin Kastenmüller; Diego A Espinosa; Lauren Trager; Cristina Stoyanov; Andres M Salazar; Santosh Pokalwar; Sanjay Singh; Sheetij Dutta; Christian F Ockenhouse; Fidel Zavala; Robert A Seder
Journal:  Infect Immun       Date:  2012-12-28       Impact factor: 3.441

Review 5.  Vitamin A and retinoic acid in the regulation of B-cell development and antibody production.

Authors:  A Catharine Ross; Qiuyan Chen; Yifan Ma
Journal:  Vitam Horm       Date:  2011       Impact factor: 3.421

6.  Microbiota Metabolite Short-Chain Fatty Acids Facilitate Mucosal Adjuvant Activity of Cholera Toxin through GPR43.

Authors:  Wenjing Yang; Yi Xiao; Xiangsheng Huang; Feidi Chen; Mingming Sun; Anthony J Bilotta; Leiqi Xu; Yao Lu; Suxia Yao; Qihong Zhao; Zhanju Liu; Yingzi Cong
Journal:  J Immunol       Date:  2019-05-10       Impact factor: 5.422

7.  Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells.

Authors:  Gustaf Lindgren; Sebastian Ols; Frank Liang; Elizabeth A Thompson; Ang Lin; Fredrika Hellgren; Kapil Bahl; Shinu John; Olga Yuzhakov; Kimberly J Hassett; Luis A Brito; Hugh Salter; Giuseppe Ciaramella; Karin Loré
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

8.  Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose.

Authors:  Zhenyu Luo; Hao Tian; Lanlan Liu; Zhikuan Chen; Ruijing Liang; Ze Chen; Zhihao Wu; Aiqing Ma; Mingbin Zheng; Lintao Cai
Journal:  Theranostics       Date:  2018-06-07       Impact factor: 11.556

9.  Use of Toll-Like Receptor Agonists to Induce Ectopic Lymphoid Structures in Myasthenia Gravis Mouse Models.

Authors:  Marieke Robinet; Bérengère Villeret; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Front Immunol       Date:  2017-08-25       Impact factor: 7.561

10.  Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4+ T Cell-Independent CD8+ T-Cell Response Against Unconjugated Protein Antigen.

Authors:  Ana L Chiodetti; María F Sánchez Vallecillo; Joseph S Dolina; María I Crespo; Constanza Marin; Stephen P Schoenberger; Daniel A Allemandi; Santiago D Palma; María C Pistoresi-Palencia; Gabriel Morón; Belkys A Maletto
Journal:  Front Immunol       Date:  2018-10-10       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.